Nu Skin Enterprises (NYSE:NUS – Get Free Report) issued an update on its FY 2026 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 0.550-0.650 for the period, compared to the consensus earnings per share estimate of 0.820. The company issued revenue guidance of $1.3 billion, compared to the consensus revenue estimate of $1.3 billion.
Analysts Set New Price Targets
Several equities research analysts have weighed in on the company. Zacks Research raised Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, October 12th. Weiss Ratings downgraded Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Reduce”.
Nu Skin Enterprises Trading Down 5.2%
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last announced its quarterly earnings data on Friday, November 6th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.11). The firm had revenue of $311.01 million during the quarter, compared to the consensus estimate of $328.70 million. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. Nu Skin Enterprises has set its FY 2026 guidance at 0.550-0.650 EPS. On average, research analysts expect that Nu Skin Enterprises will post 0.82 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 9th. Investors of record on Friday, November 27th will be issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 5.6%. The ex-dividend date is Friday, November 27th. Nu Skin Enterprises’s dividend payout ratio (DPR) is -5.37%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.
Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.
See Also
- Five stocks we like better than Nu Skin Enterprises
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
- Arista Networks Cashes In on the AI Infrastructure Buildout
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
